Veriheal

MAY 25, 2023

This is based on data gleaned by Pew Research in 2019 when two-thirds of Americans backed legalization. Among those who disagreed with legalization, 79% felt concerned about cannabis-related road safety issues, while 69% were worried that legalization could trigger a spike in other types of drug addictions. Almost half of the U.S.

Recreational 98

Recreational Legalization Cannabis Pharmaceutical 98

Cannabis Law Report

JULY 8, 2022

“Individual, licensed laboratories use different methods which may produce inconsistent results and inaccurate data on cannabis cannabinoid content. Senate Bill (SB) 544 (Laird, 2021) requires DCC to establish standardized cannabinoid test methods by January 1, 2023.

Cannabinoids 59

Cannabinoids Safety Packaging Cannabis 59

SpeedWeed

JULY 29, 2021

The SB 21-111 states that a report must be submitted to the Governor between July 1, 2022 and July 1, 2023 with details about how the CBO spends its funds. According to most recent sales data on Colorado’s cannabis industry, the state has sold $962,071,139 between January and May of this year. View original article.

Data 52

Data Collective Business Cannabis 52

Cannabis Law Report

AUGUST 6, 2021

“We’re continuing to drive cost savings and operational efficiencies across the company, and remain broadly on track to our target of $150 – $200 million in fiscal 2022- fiscal 2023,” added Mike Lee , CFO. “We First Quarter Fiscal 2022 Financial Summary. 2 Adjusted gross margin is a non-GAAP measure, and for Q1 2022 excludes $1.4

Vaping 106

Vaping Research and Development Data Business 106

Cannabis Law Report

JUNE 1, 2021

.” 1 Unless otherwise indicated, market share data disclosed in this press release is calculated using the Company’s internal proprietary market share tool that utilizes point of sales data supplied by a third-party data provider, government agencies and our own retail store operations across the country.

Data 96

Data Vaping Supply Chain Business 96

Peninsula Alternative Health

JUNE 12, 2023

With the recent passage of House Bill 556 and Senate Bill 516 in Maryland, the legalization of adult-use recreational cannabis is set to begin on July 1, 2023. This agency will build upon the existing medical cannabis program regulations and ensure health, safety, and security within the industry. Can I apply for a cannabis license?

Legislation 52

Legislation Packaging Edibles Concentrates 52

Peninsula Alternative Health

JUNE 12, 2023

With the recent passage of House Bill 556 and Senate Bill 516 in Maryland, the legalization of adult-use recreational cannabis is set to begin on July 1, 2023. This agency will build upon the existing medical cannabis program regulations and ensure health, safety, and security within the industry. Can I apply for a cannabis license?

Legislation 52

Legislation Packaging Edibles Concentrates 52

Cannabis Law Report

FEBRUARY 4, 2019

Leaf Data Systems Update. Please contact your WSLCB Enforcement Officer if you have any questions about implementation and enforcement of this important public safety rule. The expiration date of the Licensing and Enforcement System Modernization Project Account is revised from June 30, 2019 to September 1, 2023. Release 1.37.5

Topical 65

Topical Packaging Retail Legislation 65

Cannabis Law Report

AUGUST 4, 2021

We thus provide comparison with the pre-pandemic period of H1 2019 as an additional data point. from the second half of 2021 onwards as the Group fully repaid in May and June 2021 its 2022 and 2023 Eurobonds and successfully purchased a significant portion of its 2024 and 2026 Eurobonds which were bearing much higher interest rates.

Business 81

Business Research and Development Environment Food 81

Cannabis Law Report

FEBRUARY 9, 2022

But this is the first time Oregonians have been allowed to see some of the nuts and bolts of what some predict could grow into a billion-dollar industry nationally, according to Data Bridge Market Research. There are also draft rules on how facilitators will be trained to sit with people taking psilocybin to ensure safety.

Clinical Trials 52

Clinical Trials Microdosing Safety Conditions 52

Cannabis Law Report

DECEMBER 2, 2021

Recommendations and rulemaking relating to training and products were placed on an expedited timeline to ensure that facilitators will be trained, and products will be ready for the January 2, 2023, launch of the first state-sponsored psilocybin therapy program in the United States. Core Psilocybin Facilitation Skills (16 Hours).

Law 52

Law Programs Therapy Education 52

Cannabis Law Report

FEBRUARY 2, 2022

As federal legalization edges closer to reality, we believe the United States government will likely increase its role in setting the quality, consistency, and safety standards for medical and recreational cannabis products. million if the revenue generated from Lab Society’s products reaches certain milestones in 2022 and 2023.

Extraction 52

Extraction Pharmaceutical Hemp Cultivation 52

Cannabis Law Report

DECEMBER 16, 2021

Because recreational use of marijuana is increasing, especially as more states legalize it, the CDC believes it’s important for all workplaces to implement and address marijuana policies in their motor vehicle safety programs. 1, 2023, under the new law. Standardized methods must be implemented on or before Jan.

Retail 52

Retail Cannabinoids Policy Cultivation 52

Cannabis Law Report

JANUARY 20, 2022

First, a manufacturer can make an independent GRAS conclusion by determining a substance is generally recognized, “among experts qualified by scientific training and experience to evaluate its safety.” This creates an exception to the premarket approval requirement for “food additives” under the Federal Food, Drug, and Cosmetic Act.

Cannabinoids 52

Cannabinoids THC Food Hemp 52

SpeedWeed

JULY 21, 2021

From July 2017 to June 2018, the state saw $529,851,245 in taxable medical and adult-use cannabis sales, a figure that has steadily increased to $719,216,651 during the current fiscal year, which includes sales data from July 2020 to March 2021, according to the Nevada Department of Taxation.

Dispensary 52

Dispensary Packaging Terpenes Consumption 52

SpeedWeed

JULY 21, 2021

From July 2017 to June 2018, the state saw $529,851,245 in taxable medical and adult-use cannabis sales, a figure that has steadily increased to $719,216,651 during the current fiscal year, which includes sales data from July 2020 to March 2021, according to the Nevada Department of Taxation.

Cultivation 52

Cultivation Legislation Dispensary Packaging 52

Cannabis Law Report

JANUARY 9, 2022

The state’s legalization law divides cannabis tax revenue into two funds, one to support public health initiatives and the other for public safety and law enforcement training. Starting on July 1, 2023 and thereafter, 25% of the excise tax will go to the Prevention and Recovery Services Fund. 11,906,326. 13,063,204. 1 [link].

Collective 52

Collective Policy Retail Programs 52

SpeedWeed

JULY 22, 2021

From July 2017 to June 2018, the state saw $529,851,245 in taxable medical and adult-use cannabis sales, a figure that has steadily increased to $719,216,651 during the current fiscal year, which includes sales data from July 2020 to March 2021, according to the Nevada Department of Taxation.

Dispensary 52

Dispensary Packaging Terpenes Consumption 52

SpeedWeed

JULY 28, 2021

From July 2017 to June 2018, the state saw $529,851,245 in taxable medical and adult-use cannabis sales, a figure that has steadily increased to $719,216,651 during the current fiscal year, which includes sales data from July 2020 to March 2021, according to the Nevada Department of Taxation.

Dispensary 40

Dispensary Packaging Terpenes Consumption 40

Canna Law Blog

AUGUST 8, 2023

The deadline for RFI responses is August 18, 2023. The Farm Bill is renewed every five years, so policymakers are ramping up for the 2023 version on pertinent topics– including CBD and other hemp-derived cannabinoids. How should a new framework for CBD products balance consumer safety with consumer access?

CBD 98

CBD Topical Food Hemp 98

Canna Law Blog

JUNE 9, 2023

We are pleased to announce Paul Coble as a panelist moderator for the National Cannabis Industry Association (NCIA) webinar event this coming Tuesday, Jun 13, 2023 at 12:00 PM. This is especially true when the majority of cannabinoid product manufacturers are dependent on third-party data during product manufacturing and compliance testing.

Events 98

Events Cannabinoids Compliance Compliance 98

Canna Law Blog

JANUARY 17, 2023

In November 2022, the OLCC adopted and amended a suite of cannabis rules that became effective January 1, 2023. Until March 31, 2023, the notification requirements for the addition or person who would be an “applicant” remain the same. Licensees should report a recall to the OLCC within 24 hours of initiating a recall.

Retail 98

Retail Cannabis Conditions Business 98

Canna Law Blog

JANUARY 18, 2022

Corresponding to currently available scientific data it “does not appear to have any psychotropic effect or any harmful effect on human health” ( Case C-663/18 ). The new legislation takes effect in 2023. This decision conflicted with the earlier classification of CBD by the United Nations (UN). up to 0.3%.

Food 98

Food CBD Seed-To-Sale Data 98

Veriheal

JUNE 6, 2023

17 at the 2023 USA Track and Field (USATF) indoor championships in Albuquerque, New Mexico, after she had won the long jump title with a record of 6.99 Although marijuana is increasingly being decriminalized, available data reveals that it is not performance-enhancing with respect to speed, power, or strength. The post U.S.

THC 98

THC Recreational Decriminalization Sleep 98

Connor & Connor PLLC

AUGUST 15, 2024

Currently, marijuana is a Schedule I substance, meaning it is thought to have no medical value, a high probability of addiction, and a lack of any accepted safety or use in medically supervised treatment. Currently, the underground marijuana economy has an estimated value of $66 billion annually (New Frontier Data, 2023).

Marijuana 52

Marijuana DEA Policy Business 52

Cannabis Law Report

MAY 29, 2022

To mitigate safety risks, FDA implemented a Risk Evaluation and Mitigation Strategy (REMS) with elements to assure safe use (ETASU) whereby patients self-administer the spray in their healthcare provider’s office under medical supervision. 9] Experts predict that this therapy could receive full FDA approval as soon as 2023. [10]

Research and Development 52

Research and Development DEA Clinical Trials Therapy 52

The Joint Blog

JANUARY 12, 2020

billion by 2023, according to the cannabis research firm Brightfield Group and noted by the AP. Passage of the 2018 Farm Bill, which eased federal legal restrictions on hemp cultivation and transport, unleashed a stampede of companies rushing products to the market in an absence of regulations ensuring safety, quality and effectiveness.

Pets 36

Pets CBD Clinical Trials Research and Development 36

The Joint Blog

JANUARY 28, 2020

billion by 2023, according to the cannabis research firm Brightfield Group.” The growth is more rapid than I’ve seen for any product in 20 years in this business,” said Bill Bookout, president of the National Animal Supplement Council, an industry group whose member companies agree to testing and data-gathering requirements. “The

Pets 26

Pets CBD Research and Development Oil 26